Sunil Tomar

Background

About Sunil Tomar

Principal Scientist with extensive experience in analytical development for cell and gene therapies, including CAR T-cell platforms. Proven expertise in developing, optimizing, and qualifying complex plate-based, cell-based assays and ligand-binding or immunoassays (cytotoxicity, cytokine secretion: ELISA, MSD etc.) and flow cytometry-based immunophenotyping to support process development, product characterization, and GMP lot release. Skilled in applying potency matrix and assurance strategies across immune cell MOAs, with deep expertise in multi-parameter flow cytometry and immune cell functional profiling. Track record of leading cross-functional teams, driving assay transfer and qualification for clinical-stage programs, and collaborating across R&D, QC, and regulatory functions. Experienced in cGMP environments, regulatory documentation, and aligning assay strategy with FDA/EMA expectations. Committed to delivering robust analytical solutions that accelerate therapeutic development and ensure data integrity across clinical milestones.